133 related articles for article (PubMed ID: 8970634)
1. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection.
Heckl-Ostreicher B; Wosnik A; Kirschfink M
Transplantation; 1996 Dec; 62(11):1693-6. PubMed ID: 8970634
[TBL] [Abstract][Full Text] [Related]
2. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
Dalmasso AP; Platt JL
Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
[TBL] [Abstract][Full Text] [Related]
3. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
Heckl-Ostreicher B; Binder R; Kirschfink M
Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
[TBL] [Abstract][Full Text] [Related]
4. A surface-bound form of human C1 esterase inhibitor improves xenograft rejection.
Matsunami K; Miyagawa S; Yamada M; Yoshitatsu M; Shirakura R
Transplantation; 2000 Mar; 69(5):749-55. PubMed ID: 10755521
[TBL] [Abstract][Full Text] [Related]
5. C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.
Fiane AE; Videm V; Johansen HT; Mellbye OJ; Nielsen EW; Mollnes TE
Immunopharmacology; 1999 May; 42(1-3):231-43. PubMed ID: 10408384
[TBL] [Abstract][Full Text] [Related]
6. Ex-vivo hemoperfusion (eHPS) of pig-lungs with whole human blood: effects of complement inhibition with a soluble C1-esterase-inhibitor.
Schelzig H; Simon F; Krischer C; Vogel A; Abendroth D
Ann Transplant; 2001; 6(3):34-9. PubMed ID: 11899895
[TBL] [Abstract][Full Text] [Related]
7. C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation.
Hecker JM; Lorenz R; Appiah R; Vangerow B; Loss M; Kunz R; Schmidtko J; Mengel M; Klempnauer J; Piepenbrock S; Dickneite G; Neidhardt H; Rückoldt H; Winkler M
Transplantation; 2002 Mar; 73(5):688-94. PubMed ID: 11907412
[TBL] [Abstract][Full Text] [Related]
8. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of C1 inhibitor plus heparin in prevention of complement-mediated activation of endothelial cells in a model of xenograft hyperacute rejection.
Dalmasso AP; Platt JL
Transplant Proc; 1994 Jun; 26(3):1246-7. PubMed ID: 8029898
[No Abstract] [Full Text] [Related]
10. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
[TBL] [Abstract][Full Text] [Related]
11. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B
Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977
[TBL] [Abstract][Full Text] [Related]
13. Controlling the complement system in inflammation.
Kirschfink M
Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
[TBL] [Abstract][Full Text] [Related]
14. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
15. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
[TBL] [Abstract][Full Text] [Related]
16. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
[TBL] [Abstract][Full Text] [Related]
17. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.
Schröder C; Pfeiffer S; Wu G; Zorn GL; Ding L; Allen C; Harrison RA; White DJ; Azimzadeh AM; Pierson RN
J Heart Lung Transplant; 2003 Dec; 22(12):1365-75. PubMed ID: 14672751
[TBL] [Abstract][Full Text] [Related]
18. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.
van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP
Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human C1-inhibitor inhibits cytotoxicity induced by allo- and xenoantibodies.
Poirier N; Blancho G
Transplant Proc; 2008 Mar; 40(2):581-3. PubMed ID: 18374134
[TBL] [Abstract][Full Text] [Related]
20. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
